|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/574 |
| (11) | Patento numeris | 2742149 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12743901.6 |
| Europos patento paraiškos padavimo data | 2012-08-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-06-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-01-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/003339 |
| Data | 2012-08-04 |
| (87) | Numeris | WO 2013/020690 |
| Data | 2013-02-14 |
| (30) | Numeris | Data | Šalis |
| 201113205469 | 2011-08-08 | US |
| (72) |
LI, Yan, US
LIH, Chih-Jian, US
LIU, Wei-Min, US
TAI, Yu Chuan, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
Roche Diagnostics GmbH, Sandhofer Strasse 116, 68305 Mannheim, DE |
| (54) | PREDICTING RESPONSE TO ANTI-CD20 THERAPY IN DLBCL PATIENTS |
| PREDICTING RESPONSE TO ANTI-CD20 THERAPY IN DLBCL PATIENTS |